ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Helping Biotechs Overcome 4 Key Challenges

  Delays in site payments, participant reimbursements, and logistical inefficiencies can create roadblocks for patients and sites.

• eClinical Platform Accelerates COVID-19 Treatment Trial By 2 Weeks

  Examine a COVID-19 treatment trial that utilized integrated EDC, eConsent, eCOA, RTSM, and TeleVisit solutions, all within a single platform, to address three critical challenges.

• Tackling Feasibility In Rare Disease Clinical Trials

  Rare disease clinical trials face distinct challenges, but the right data strategy can offer a transformative approach to addressing complexities and enhancing enrollment.

• Benefits Of Using ePRO In Early Phase Studies

  Discover how harnessing Patient Reported Outcomes electronically in early-phase trials can boost patient centricity, create more cost-effective operations, and help generate better data faster.

• Transforming Field Rep Success

  As the healthcare landscape evolves, maintaining accurate and timely information delivery becomes vital for building strong HCP relationships and improving patient outcomes.

• Virtual eConsent For Decentralized Trials

  Virtual eConsent improves accessibility and compliance in decentralized trials, streamlining enrollment with a secure, user-friendly process for informed consent in remote research.

• The AI Revolution In Clinical Trials

  AI is reshaping clinical trials by accelerating patient recruitment, optimizing protocol design, and improving data quality—driving faster, more efficient, and more inclusive research outcomes.

• Overcoming 5 Challenges Of Implementing eClinical Technologies

  Assess five common pitfalls trial teams face when incorporating new technology and identify potential solutions to mitigate the common risks.

• Why More Sponsors Are Taking Control Of Clinical Trial Study Builds

  Accelerate study startup and reduce rework by building studies directly in EDC. Discover a more flexible, efficient approach to managing clinical trials and data quality.

• Real-Time Trials Need Real-Time Data You Can Trust

  The FDA just kicked off real-time clinical trials with AstraZeneca and Amgen. But speed means nothing if the underlying data is inconsistent.